Cell therapy medicinal product regulatory framework in Europe and its application for MSC-based therapy development (Q36162423)

12 August 2017

Cell therapy medicinal product regulatory framework in Europe and its application for MSC-based therapy development (English)

1 reference

12 August 2017

Janis Ancans

1

1 reference

12 August 2017

14 August 2012

1 reference

12 August 2017

Frontiers in Immunology

1 reference

12 August 2017

3

1 reference

12 August 2017

253

1 reference

Clinical applications of mesenchymal stem cells

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3418507

Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3418507

Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3418507

Adaptive licensing: taking the next step in the evolution of drug approval

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3418507

The European hospital exemption clause-new option for gene therapy?

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3418507

Medical therapies with adult stem/progenitor cells (MSCs): a backward journey from dramatic results in vivo to the cellular and molecular explanations

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3418507

Genetically engineered mesenchymal stem cells as a proposed therapeutic for Huntington's disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3418507

The legal landscape for advanced therapies: material and institutional implementation of European Union rules in France and the United Kingdom.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3418507

Korea okays stem cell therapies despite limited peer-reviewed data.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3418507

Challenges with advanced therapy medicinal products and how to meet them.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3418507

Factors associated with success of market authorisation applications for pharmaceutical drugs submitted to the European Medicines Agency

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3418507

21 October 2018

Identifiers

DOI

10.3389/FIMMU.2012.00253

1 reference

release_x4hethuqqbgulcosa76ljxog5m

12 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/x4hethuqqbgulcosa76ljxog5m

mapped directly with Wikidata item

24 November 2022

based on heuristic

PMC publication ID

3418507

1 reference

PMC publication ID

3418507

12 August 2017

PubMed publication ID

22912639

1 reference

PMC publication ID

3418507